- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/42 - Sulfur atoms
Patent holdings for IPC class C07D 233/42
Total number of patents in this class: 40
10-year publication summary
|
0
|
1
|
2
|
1
|
2
|
4
|
3
|
3
|
1
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Arvinas Operations, Inc. | 229 |
7 |
| President and Fellows of Harvard College | 5986 |
2 |
| Abbvie Inc. | 1800 |
2 |
| AbbVie Deutschland GmbH & Co. KG | 261 |
2 |
| Arkema France | 4154 |
2 |
| Denali Therapeutics Inc. | 246 |
2 |
| Suzhou Kintor Pharmaceuticals, Inc. | 59 |
2 |
| Petroliam Nasional Berhad | 50 |
2 |
| F. Hoffmann-La Roche AG | 7947 |
1 |
| BASF SE | 20940 |
1 |
| Merck Sharp & Dohme Corp. | 2191 |
1 |
| Ardea Biosciences, Inc. | 72 |
1 |
| BioMarin Pharmaceutical Inc. | 374 |
1 |
| Cymabay Therapeutics, Inc. | 110 |
1 |
| Endorecherche, Inc. | 24 |
1 |
| Irm LLC | 157 |
1 |
| Janssen Sciences Ireland UC | 183 |
1 |
| Ranbaxy Laboratories Limited | 307 |
1 |
| The Scripps Research Institute | 1346 |
1 |
| Technion Research & Development Foundation Ltd. | 1214 |
1 |
| Other owners | 7 |